Swiss pharmaceutical giant Roche says it wants to buy California-based Genentech, maker of three of the best-selling cancer drugs in America. But Genentech's not going to come as cheap as Roche is hoping -- if the deal goes down at all. Janet Babin reports.
After keeping the foreign brewer at bay, Anheuser-Busch is warming up to takeover bids from Stella Artois producer InBev. Kyle James reports the potential deal would create the world's largest brewer.
Dow Chemical is paying more than $15 billion for Rohm and Haas, a maker of specialty chemical products. Alisa Roth has more details about the deal and why Dow considers it "game-changing" for the company.
Media titans are in Idaho this week for the 25th Sun Valley conference, but the same old big media isn't making money like it used to. Ashley Milne-Tyte reports it may be time for media Web sites to shine.
If the board of directors isn't on your side, why not try to have them replaced? That's what InBev is attempting to do with the heads of Anheuser-Busch to help its bid for the company. Alisa Roth reports.
Apparently, Microsoft's not used to rejection. Despite being rebuffed, the computer giant is still looking for a way to get a piece of Yahoo's search market. Stacey Vanek-Smith reports.
Blockbuster has taken back its billion-dollar bid for electronics chain Circuit City. Weak sales and stiff competition are partially to blame. Amy Scott reports Circuit City may still be looking for a buyer.
Stella Artois parent InBev is warning Anheuser-Busch that it could get hostile. Stephen Beard reports InBev is prepared to make an appeal directly to shareholders, some who are receptive to the company's bid.
Countrywide is officially part of Bank of America, but in the six months since B of A agreed to buy the mortgage company, Countrywide's losses continued to build up. Jill Barshay reports.